Liminatus Pharma, Inc. LIMN
Set alert
2.69 USD -0.06 -2.29%
As of Nov 2, 3:28 PM ET
2.69 Day range 2.97
2.69 52-week range 141.50
- YTD
- -91.19%
- 1 year
- -96.13%
- Open
- 2.97
- Prev close
- 2.75
- Mkt cap
- 3.61M
- Vol
- 20.31K
- Avg vol
- 221.94K
- EPS
- -23.50
- P/E
- 0.00
- Div yield
- 0.00%
More statistics
- Low
- 2.69
- High
- 2.97
Financials — quick view
LIMN Revenue — quarterly 0
LIMN Net income — quarterly -1.41M
LIMN EPS — quarterly -1.50
News
- Liminatus Pharma Regains Compliance With Nasdaq’s Minimum Bid Price Rule
- Liminatus Pharma Regains Compliance with Nasdaq Minimum Bid Price Rule
- 12 Health Care Stocks Moving In Wednesday's After-Market Session
- Liminatus Pharma Engages Synex Consulting To Support Clinical Development Of IBC101, CD19xCD22 Bivalent CAR-T Cell Therapy Candidate
- Liminatus Pharma Engages Synex as Contract Research Organization to Support Phase 1/2a Clinical Development of CD19xCD22 bivalent CAR-T therapy
- 12 Health Care Stocks Moving In Tuesday's After-Market Session
- Liminatus Pharma Board Adopts Resolutions Approving Reverse Stock Split Of Its Common Stock At Ratio Of 1-For-50
- Liminatus Pharma, Inc. Announces Reverse Stock Split of its Common Stock
- 12 Health Care Stocks Moving In Thursday's Intraday Session
- 12 Health Care Stocks Moving In Thursday's Pre-Market Session
Your note
Sign in to keep a note on LIMN — it syncs with the Stock Master app.